These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


286 related items for PubMed ID: 15239662

  • 21. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W, Borch RF.
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [Abstract] [Full Text] [Related]

  • 22. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
    Fukuda Y, Furuta H, Kusama Y, Ebisu H, Oomori Y, Terashima S.
    J Med Chem; 1999 Apr 22; 42(8):1448-58. PubMed ID: 10212131
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S, Zhang J, Li J, Chen D, Matteucci M, Curd J, Duan JX.
    Biol Trace Elem Res; 2010 Sep 22; 136(3):294-301. PubMed ID: 19838642
    [Abstract] [Full Text] [Related]

  • 27. 1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards.
    Springer JB, Chang YH, Koo KI, Colvin OM, Colvin ME, Dolan ME, Delaney SM, Flowers JL, Ludeman SM.
    Chem Res Toxicol; 2004 Sep 22; 17(9):1217-26. PubMed ID: 15377155
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and biological evaluation of mercapto triazolo-benzothiadiazine linked aminobenzothiazoles as potential anticancer agents.
    Kamal A, Khan MN, Srikanth YV, Rajesh SV.
    Chem Biol Drug Des; 2009 Jun 22; 73(6):687-93. PubMed ID: 19635062
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
    Argade AB, Devraj R, Vroman JA, Haugwitz RD, Hollingshead M, Cushman M.
    J Med Chem; 1998 Aug 27; 41(18):3337-46. PubMed ID: 9719586
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis of cryptolepine analogues as potential bioreducible anticancer agents.
    Seville S, Phillips RM, Shnyder SD, Wright CW.
    Bioorg Med Chem; 2007 Oct 01; 15(19):6353-60. PubMed ID: 17643990
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM, Wodinsky I, Myles A.
    Cancer Treat Rep; 1976 Apr 01; 60(4):337-46. PubMed ID: 1277209
    [Abstract] [Full Text] [Related]

  • 37. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH, Moon KY, Baturay N, Shirota FN.
    J Med Chem; 1991 Feb 01; 34(2):588-92. PubMed ID: 1995881
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Design, synthesis and biological activity of protaxols.
    Nicolaou KC, Riemer C, Kerr MA, Rideout D, Wrasidlo W.
    Nature; 1993 Jul 29; 364(6436):464-6. PubMed ID: 8101355
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.